Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/Mel47)

PURPOSE: A CTEP-sponsored phase II trial was performed to evaluate safety and clinical activity of combination therapy with CCI-779 (temsirolimus) and bevacizumab in patients with advanced melanoma. EXPERIMENTAL DESIGN: Patients with unresectable stage III to IV melanoma were treated intravenously w...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Slingluff, Craig L., Petroni, Gina R, Molhoek, Kerrington R., Brautigan, David L., Chianese-Bullock, Kimberly A., Shada, Amber L., Smolkin, Mark E., Olson, Walter C., Gaucher, Alison, Chase, Cheryl Murphy, Grosh, William W., Weiss, Geoffrey R., Wagenseller, Aubrey G., Olszanski, Anthony J., Martin, Lainie, Shea, Sofa M., Erdag, Gulsun, Ram, Prahlad, Gershenwald, Jeffrey E., Weber, Michael J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700572/
https://ncbi.nlm.nih.gov/pubmed/23620404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3919
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים